![]() | Up a level |
2017
Burmester, Gerd R., McInnes, Iain B., Kremer, Joel, Miranda, Pedro, Korkosz, Mariusz, Vencovsky, Jiri ORCID: 0000-0002-0851-0713, Rubbert-Roth, Andrea, Mysler, Eduardo, Sleeman, Matthew A., Godwood, Alex, Sinibaldi, Dominic, Guo, Xiang, White, Wendy I., Wang, Bing, Wu, Chi-Yuan, Ryan, Patricia C., Close, David and Weinblatt, Michael E.
(2017).
A randomised phase IIb study of mavrilimumab, a novel GM-CSF receptor alpha monoclonal antibody, in the treatment of rheumatoid arthritis.
Ann. Rheum. Dis., 76 (6).
S. 1020 - 1031.
LONDON:
BMJ PUBLISHING GROUP.
ISSN 1468-2060
2014
Burmester, Gerd, McInnes, Iain B., Kremer, Joel M., Miranda, Pedro, Korkosz, Mariusz, Vencovsky, Jiri ORCID: 0000-0002-0851-0713, Rubbert-Roth, Andrea, Mysler, Eduardo, Sandbach, Sara, Sleeman, Matthew A., Godwood, Alex, Close, David and Weinblatt, Michael
(2014).
Efficacy and Safety/Tolerability of Mavrilimumab, a Human GM-CSFRa Monoclonal Antibody in Patients with Rheumatoid Arthritis.
Arthritis Rheumatol., 66.
S. S1231 - 2.
HOBOKEN:
WILEY-BLACKWELL.
ISSN 2326-5205
McInnes, Iain B., Burmester, Gerd, Kremer, Joel M., Miranda, Pedro, Korkosz, Mariusz, Vencovsky, Jiri ORCID: 0000-0002-0851-0713, Rubbert-Roth, Andrea, Mysler, Eduardo, Close, David, Sleeman, Matthew A., Godwood, Alex, Sandbach, Sara, Ryan, Patricia C., Sinibaldi, Dominic, White, Wendy, Defranoux, Nadine A. and Weinblatt, Michael
(2014).
Rapid Onset of Clinical Benefit Is Associated with a Reduction in Validated Biomarkers of Disease in Patients with Rheumatoid Arthritis Treated with Mavrilimumab, a Human Monoclonal Antibody Targeting GM-CSFRa.
Arthritis Rheumatol., 66.
S. S653 - 2.
HOBOKEN:
WILEY-BLACKWELL.
ISSN 2326-5205